India’s Healthcare Business Daily
Search the archive
Key Coverage
Follow IndiaMedToday
Topic
1 article
Receives regulatory approval for its molecule ‘Selumetinib’ in India AstraZeneca India announced its entry into rare disease therapy in India.…